Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH
Zutectra, a human hepatitis B immunoglobulin, has been authorised by the EMA for use in immunization, with indications including hepatitis B…
-
EMA approval · 2026-08-07EMA Authorised: Hexacima (hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett);Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein;tetanus toxoid) — Sanofi Winthrop Industrie
EMA authorised Hexacima, a combination vaccine covering hepatitis B, diphtheria, pertussis, poliomyelitis, Haemophilus influenzae type b, te…
-
EMA approval · 2026-08-07EMA Authorised: Hexyon (filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid) — Sanofi Winthrop Industrie
EMA has authorised Hexyon, a combined immunization vaccine covering multiple diseases including hepatitis B, diphtheria, tetanus, pertussis,…
-
EMA approval · 2026-08-04EMA Authorised: Twinrix Adult (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Twinrix Adult (hepatitis A virus inactivated + hepatitis B surface antigen) has been authorised for use in adults by the EMA.
-
EMA approval · 2026-08-03EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
The EMA has authorised Twinrix Paediatric, a combined hepatitis A and B vaccine for children, under the marketing authorization holder Glaxo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-08-03EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Ambirix, a vaccine containing inactivated hepatitis A virus and hepatitis B surface antigen, has been authorised for immunization against he…
-
EMA approval · 2026-07-10EMA Authorised: Fendrix (hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Fendrix has been authorised by the EMA for use in its hepatitis B immunization program.
-
EMA approval · 2026-07-10EMA Authorised: Infanrix Hexa (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);hepatitis B surface antigen;poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain));Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
EMA has authorised Infanrix Hexa, a hexavalent vaccine by GlaxoSmithKline Biologicals S.A., covering multiple antigens including diphtheria,…
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating the effect of Bepirovirsen on cardiac conduction in healthy volunteers; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Clinical trial results in Zambian HIV-HBV co-infected patients evaluated liver fibrosis outcomes; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection [Phase 1, Phase 2]
Phase 1/2 study of GSK3965193 in healthy participants and individuals with chronic Hepatitis B was terminated; results posted.
-
EMA approval · 2026-06-12EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH
Zutectra, a human hepatitis B immunoglobulin product by Biotest Pharma GmbH, has been authorised for use in immunization and passive immunit…
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection [Phase 2]
Phase 2 open-label study results of AB-729 (nucleos(t)ide analogue) combined with pegylated interferon alfa-2a in chronic hepatitis B; study…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
A completed clinical trial update examining whether Hepatitis B and Hepatitis C infections are risk factors for hepatocellular carcinoma amo…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer [NA]
This clinical trial update describes a study evaluating GAAD score plus AFP/PIVKA-II or ultrasound for surveillance of people at risk for he…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
This clinical trial is evaluating the cellular immune response after Hepatitis B vaccination and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis [Phase 1]
A Phase 1 clinical trial is evaluating hUC mesenchymal stem cells (19#iSCLife®-LC) for decompensated hepatitis B cirrhosis. The study is spo…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection [Phase 2]
Vir Biotechnology reports that the Phase 2 study of VIR-2218, VIR-3434, and PEG-IFNα for chronic hepatitis B infection has been completed. T…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
This completed clinical trial examines social, environmental, psychosocial, behavioral, clinical, and biological factors that drive disparit…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
This update describes a long-term observational study following participants who have received PBGENE-HBV to assess outcomes in chronic hepa…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis [NA]
This clinical trial evaluates whether Babao Dan Capsule in combination with antiviral therapy can reduce the incidence of hepatocellular car…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV [Phase 2]
Phase 2 trial of the oral TLR8 agonist Selgantolimod (GS-9688) on HBsAg in participants with chronic hepatitis B and HIV has completed.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: TAF vs TDF During the Pregancy [Phase 4]
A Phase 4 clinical trial comparing tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) in pregnant women with hepatitis B is…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients [NA]
Clinical trial investigating fine-needle aspiration to evaluate the intrahepatic HBV reservoir and its immune characteristics in patients wi…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults [Phase 1]
A phase 1 clinical trial is evaluating the safety and immunogenicity of an investigational hepatitis B vaccine in healthy adults. The study,…